Cargando…

Interaction of graphene nanoribbons with components of the blood vascular system

AIM: The systemic administration of graphene nanoribbons for a variety of in vivo biomedical applications will result in their interaction with cellular and protein components of the circulatory system. The aim of this study was to assess the in vitro effects of graphene nanoribbons (O-GNR) noncoval...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Sayan Mullick, Fang, Justin, Sitharaman, Balaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765390/
https://www.ncbi.nlm.nih.gov/pubmed/26925250
http://dx.doi.org/10.4155/fso.15.17
Descripción
Sumario:AIM: The systemic administration of graphene nanoribbons for a variety of in vivo biomedical applications will result in their interaction with cellular and protein components of the circulatory system. The aim of this study was to assess the in vitro effects of graphene nanoribbons (O-GNR) noncovalently functionalized with PEG-DSPE (1, 2-distearoyl-sn-glycero-3-phosphoethanolamine-N [amino (polyethylene glycol)]) on some of the key hematological and vascular components of the circulatory system. METHODS: Transmission electron microscopy was used to characterize the nanoparticles. ELISA-based assays, bright-field microscopy, transmission electron microscopy and colorimetric assays were used to assess toxicological effects. RESULTS: Our findings taken together indicate that low concentrations of O-GNR-PEG-DSPE (<80 µg/ml) are relatively nontoxic to the hematological components, and could be employed for diagnostic and therapeutic applications especially for diseases of the circulatory system.